NuVasive
In Howard Marks's portfolio · Oaktree Capital Management
Ticker NUVA.CV
Not in the portfolio as of Q2 2026. Every quarter it shows up in a Oaktree Capital Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q4 2023 | Reduce 5% | 18,934,000 | 0.3% |
| Q3 2023 | Reduce 26% | 19,933,000 | 0.3% |
| Q2 2023 | Add 6% | 26,961,000 | 0.3% |
| Q1 2023 | Add 72% | 25,492,000 | 0.2% |
| Q3 2017 | Sell | 0 | |
| Q2 2017 | Reduce 21% | 26,555,000 | 0.6% |
| Q1 2017 | Buy | 33,765,000 | 0.7% |
| Q3 2015 | Reduce 15% | 55,053,000 | 0.9% |
| Q2 2015 | Reduce 23% | 65,053,000 | 1.0% |
| Q1 2015 | Add 3% | 84,553,000 | 1.1% |
| Q4 2014 | Reduce 2% | 82,053,000 | 1.1% |
| Q3 2014 | No change | 83,710,000 | 1.6% |
| Q2 2014 | Add 1% | 83,710,000 | 1.7% |
| Q1 2014 | Add 14% | 82,525,000 | 1.9% |
| Q4 2013 | Add 985% | 72,120,000 | 1.4% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.